Incyte
INCY
#1191
Rank
โ‚น1.827 T
Marketcap
โ‚น9,182
Share price
0.20%
Change (1 day)
43.38%
Change (1 year)

Incyte (INCY) - P/B ratio

P/B ratio as of February 2026 : 3.89

According to Incyte's latest financial reports the company has a price-to-book ratio of 4.17826.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Incyte - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-314.2810.66%
2024-12-313.8742.67%
2023-12-312.71-33.69%
2022-12-314.09-4.92%
2021-12-314.30-41.04%
2020-12-317.290.41%
2019-12-317.263.17%
2018-12-317.04-42.55%
2017-12-3112.3-72.78%
2016-12-3145.0-61.92%
2015-12-31118-177.28%
2014-12-31-153258.15%
2013-12-31-42.7237.25%
2012-12-31-12.751.76%
2011-12-31-8.35-63.75%
2010-12-31-23.0117.7%
2009-12-31-10.6534.11%
2008-12-31-1.67-68.68%
2007-12-31-5.33-7.79%
2006-12-31-5.78-74.9%
2005-12-31-23.0-317.87%
2004-12-3110.6228.54%
2003-12-313.22217.4%
2002-12-311.01

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
6.94 78.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.66-57.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
37.0 852.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
21.5 451.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
3.91 0.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
5.01 28.61%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-47.3-1,315.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
18.1 364.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
10.3 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA